SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-302660
Filing Date
2019-11-27
Accepted
2019-11-27 16:55:29
Documents
2
Group Members
MARC A. SINGEROSAGE UNIVERSITY GP III, LLCROBERT S. ADELSONWILLIAM T. HARRINGTON

Document Format Files

Seq Description Document Type Size
1 SC 13G d747348dsc13g.htm SC 13G 93414
2 EX-99.1 d747348dex991.htm EX-99.1 5087
  Complete submission text file 0001193125-19-302660.txt   100282
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91126 | Film No.: 191258752
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 MONUMENT ROAD BALA CYNWYD PA 19004
Business Address 50 MONUMENT ROAD BALA CYNWYD PA 19004 (484) 434-2255
Osage University Partners III, LP (Filed by) CIK: 0001743036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G